FYN and Alzheimer disease: Notably, the reduction of Fyn TK activity using either molecular or pharmacologic strategies, such as Fyn TK inhibitors (TKI: Saracatinib and Masitinib), prevents APP Tyr682 phosphorylation and Aβ accumulation and protects AD neurons from death [15,17].